Moreover, the expression of co-stimulatory molecules in DCs from psoriasis skin diminished during etanercept therapy16 and in vitro-derived DC from rheumatoid arthritis patients receiving anti-TNF displayed impaired upregulation of co-stimulatory molecules and poor T-cell stimulatory activity28. The gene discussed is TNF; the disease is psoriasis.